LGALS3 and hydrops fetalis: The primary objective is to determine the effect of carvedilol on echocardiographic measures of cardiac remodeling and the risk of HF, including the LV wall thickness:dimension ratio, LVEF, LV volume, and serum biomarker concentrations (natriuretic peptides, galectin-3) that are associated with increased risk for HF.